CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES

活化人类白细胞的临床试验

• 批准号: 3614786
• 负责人: FREDERICK R ARONSON
• 金额: --
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-06-30 至 1991-06-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3614786
• 关键词: CLINICAL; TRIALS; ACTIVATED; HUMAN; LEUKOCYTES

项目成果

Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.

使用白细胞介素 2 和淋巴因子激活的杀伤细胞治疗肾细胞癌：混合推注和连续输注白细胞介素 2 方案的 II 期经验。

• DOI: 10.1200/jco.1990.8.10.1630
• 发表时间: 1990
• 期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• 作者: Parkinson,DR;Fisher,RI;Rayner,AA;Paietta,E;Margolin,KA;Weiss,GR;Mier,JW;Sznol,M;Gaynor,ER;Bar,MH
• 通讯作者: Bar,MH

Phase II trial of high-dose interleukin-2 and lymphokine-activated killer cells in Hodgkin's disease and non-Hodgkin's lymphoma.

高剂量白介素 2 和淋巴因子激活杀伤细胞治疗霍奇金病和非霍奇金淋巴瘤的 II 期试验。

• DOI: 10.1097/00002371-199106000-00008
• 发表时间: 1991
• 期刊: Journal of immunotherapy : official journal of the Society for Biological Therapy
• 作者: Margolin,KA;Aronson,FR;Sznol,M;Atkins,MB;Ciobanu,N;Fisher,RI;Weiss,GR;Doroshow,JH;Bar,MH;Hawkins,MJ
• 通讯作者: Hawkins,MJ

A phase I study of high-dose interleukin-2 in combination with interferon-alpha 2b.

高剂量白细胞介素 2 与干扰素 α 2b 联合的 I 期研究。

• 发表时间: 1990
• 期刊: Journal of biological response modifiers
• 作者: Sznol,M;Mier,JW;Sparano,J;Gaynor,ER;Weiss,GR;Margolin,KA;Bar,MH;Hawkins,MJ;Atkins,MB;Dutcher,JP
• 通讯作者: Dutcher,JP

A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinoma.

白细胞介素-2 和淋巴因子激活杀伤细胞治疗晚期结直肠癌的 II 期临床试验。

• DOI: 10.1097/00002371-199401000-00010
• 发表时间: 1994
• 期刊: Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy
• 作者: Hawkins,MJ;Atkins,MB;Dutcher,JP;Fisher,RI;Weiss,GR;Margolin,KA;Rayner,AA;Sznol,M;Parkinson,DR;Paietta,E
• 通讯作者: Paietta,E

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.

连续输注白细胞介素 2 或推注白细胞介素 2 加淋巴因子激活杀伤细胞治疗晚期肾细胞癌的随机 II 期试验。

• DOI: 10.1200/jco.1992.10.2.275
• 发表时间: 1992
• 期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• 作者: Weiss,GR;Margolin,KA;Aronson,FR;Sznol,M;Atkins,MB;Dutcher,JP;Gaynor,ER;Boldt,DH;Doroshow,JH;Bar,MH
• 通讯作者: Bar,MH